Jefferies Group LLC Enanta Pharmaceuticals Inc Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$43.36 - $53.53 $260,160 - $321,180	-6,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $278,220 - $345,480	6,000 New	6,000 $301,000
Q3 2019 Nov 13, 2019	SELL	$60.08 - $88.17 $431,374 - $633,060	-7,180 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $493,003 - $590,330	6,064 Added 543.37%	7,180 $606,000
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $77,093 - $117,916	1,116 New	1,116 $107,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $198M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.